FOIA request to the U.S. Food and Drug Administration seeking communications sent by Peripheral and Central Nervous System Drugs Advisory Committee members regarding Aduhelm (aducanumab), an Alzheimer’s drug produced by Biogen. HHS-FDA-22-0116